These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 6690033)
41. Effect of ciprofloxacin on the disposition of 14C-dideoxyinosine-derived radioactivity in the rat. Gallicano KD; Buttar HS; Moffatt JH Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):163-74. PubMed ID: 8321920 [TBL] [Abstract][Full Text] [Related]
42. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice. Sauer JM; Bao J; Smith RL; Kuester RK; Mayersohn M; Sipes IG Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522 [TBL] [Abstract][Full Text] [Related]
43. Plasma clearance and tissue distribution of partially thiolated polycytidylic acid and its degradation products in rodents. Kung MP; Ho YK; Lalka D; Bardos TJ Cancer Res; 1984 Oct; 44(10):4602-6. PubMed ID: 6467215 [TBL] [Abstract][Full Text] [Related]
44. Main metabolites of 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha, beta-D-ribofuranosyl]-1-nitrosourea and 1-(2-chloroethyl)-3-(2',3', 4'-tri-O-acetyl-alpha, beta-D-ribopyranosyl)-1-nitrosourea in rats. Madelmont JC; Moreau MF; Godeneche D; Duprat J; Plagne R; Meyniel G Drug Metab Dispos; 1982; 10(6):662-6. PubMed ID: 6130919 [TBL] [Abstract][Full Text] [Related]
45. Disposition and metabolism of finasteride in dogs. Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636 [TBL] [Abstract][Full Text] [Related]
46. Disposition and metabolism of [14C]dibenzo[c,g]carbazole aerosols in rats after inhalation. Bond JA; Ayres PH; Medinsky MA; Cheng YS; Hirshfield D; McClellan RO Fundam Appl Toxicol; 1986 Jul; 7(1):76-85. PubMed ID: 3732674 [TBL] [Abstract][Full Text] [Related]
48. Disposition and metabolism of a novel antineoplastic agent, 4-tert-butyl-[3-(2-chloroethyl)ureido]benzene, in mice. Maurizis JC; Rapp M; Azim EM; Gaudreault RC; Veyre A; Madelmont JC Drug Metab Dispos; 1998 Feb; 26(2):146-51. PubMed ID: 9456301 [TBL] [Abstract][Full Text] [Related]
49. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review. Setnikar I; Rovati LC Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003 [TBL] [Abstract][Full Text] [Related]
50. Biodistribution of 14C-lomustine in an animal tumor model. Castronovo FP; Potsaid MS; Kopiwoda SY J Pharm Sci; 1980 Jan; 69(1):87-9. PubMed ID: 7354451 [TBL] [Abstract][Full Text] [Related]
51. Disposition, pharmacokinetics, and metabolism of 14C-fotemustine in cancer patients. Ings RM; Gray AJ; Taylor AR; Gordon BH; Breen M; Hiley M; Brownsill R; Marchant N; Richards R; Wallace D Eur J Cancer; 1990; 26(7):838-42. PubMed ID: 2145908 [TBL] [Abstract][Full Text] [Related]
52. Distribution of Bratton-Marshall-positive material in mice following intravenous injections of nitrosoureas. Kari P; McConnell WR; Finkel JM; Hill DL Cancer Chemother Pharmacol; 1980; 4(4):243-8. PubMed ID: 7438326 [TBL] [Abstract][Full Text] [Related]
53. Differential distribution and covalent binding of two labeled forms of methyl-CCNU in the Fischer 344 rat. Kramer RA; McMenamin MG; Boyd MR Cancer Chemother Pharmacol; 1985; 14(2):150-5. PubMed ID: 3971479 [TBL] [Abstract][Full Text] [Related]
54. Disposition of new sulphur-containing 2-(chloroethyl)nitrosoureas in rats. Godenèche D; Madelmont JC; Labarre P; Plagne R; Meyniel G Xenobiotica; 1987 Jan; 17(1):59-70. PubMed ID: 3825177 [TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetic studies on 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077). III. Pharmacokinetics of a new nitrosourea antitumor agent TA-077 in humans (a phase I study). Hayashida K; Miura Y; Arai Y; Takeyama S; Wakui A; Yokoyama M; Kanamaru R; Majima H; Taguchi T; Ohmichi M J Pharmacobiodyn; 1987 Oct; 10(10):523-7. PubMed ID: 3440914 [TBL] [Abstract][Full Text] [Related]
56. The comparative disposition of [14C]-fotemustine in non-tumourous and tumourous mice. Ings RM; Breen M; Devereux K; Gray AJ; Edwards FE; Lucas C; Briggs M; Robinson BV; Campbell DB Cancer Chemother Pharmacol; 1990; 27(2):106-10. PubMed ID: 2249325 [TBL] [Abstract][Full Text] [Related]
57. Protein mediated chemical reactions of chloroethylnitrosoureas. Weinkam RJ; Liu TY; Lin HS Chem Biol Interact; 1980 Aug; 31(2):167-77. PubMed ID: 7389008 [TBL] [Abstract][Full Text] [Related]
58. Tissue distribution and excretion of radioactivity following administration of 14C-labeled deoxynivalenol to White Leghorn hens. Prelusky DB; Hamilton RM; Trenholm HL; Miller JD Fundam Appl Toxicol; 1986 Nov; 7(4):635-45. PubMed ID: 3803758 [TBL] [Abstract][Full Text] [Related]
59. Whole-body autoradiographic studies on tissue distribution of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride in tumor-bearing mice and rats. Shigehara E; Tanaka M Gan; 1978 Oct; 69(5):709-14. PubMed ID: 729969 [No Abstract] [Full Text] [Related]
60. Intracarotid infusion of PCNU (NSC: 95466): preclinical toxicological study in dogs. Goumnerova L; Richard MT; Addison D; Montpetit V; Stewart DJ J Neurooncol; 1987; 5(3):205-9. PubMed ID: 3681384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]